BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17625607)

  • 1. MicroRNA losses in the frequently deleted region of 7q in SMZL.
    Ruiz-Ballesteros E; Mollejo M; Mateo M; Algara P; Martínez P; Piris MA
    Leukemia; 2007 Dec; 21(12):2547-9. PubMed ID: 17625607
    [No Abstract]   [Full Text] [Related]  

  • 2. High-throughput sequencing analysis of the chromosome 7q32 deletion reveals IRF5 as a potential tumour suppressor in splenic marginal-zone lymphoma.
    Fresquet V; Robles EF; Parker A; Martinez-Useros J; Mena M; Malumbres R; Agirre X; Catarino S; Arteta D; Osaba L; Mollejo M; Hernandez-Rivas JM; Calasanz MJ; Daibata M; Dyer MJ; Prosper F; Vizcarra E; Piris MÁ; Oscier D; Martinez-Climent JA
    Br J Haematol; 2012 Sep; 158(6):712-26. PubMed ID: 22816737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splenic marginal zone lymphoma: characterization of 7q deletion and its value in diagnosis.
    Watkins AJ; Huang Y; Ye H; Chanudet E; Johnson N; Hamoudi R; Liu H; Dong G; Attygalle A; McPhail ED; Law ME; Isaacson PG; de Leval L; Wotherspoon A; Du MQ
    J Pathol; 2010 Mar; 220(4):461-74. PubMed ID: 20077527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A narrow deletion of 7q is common to HCL, and SMZL, but not CLL.
    Andersen CL; Gruszka-Westwood A; Østergaard M; Koch J; Jacobsen E; Kjeldsen E; Nielsen B
    Eur J Haematol; 2004 Jun; 72(6):390-402. PubMed ID: 15128417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA expression profile in splenic marginal zone lymphoma.
    Bouteloup M; Verney A; Rachinel N; Callet-Bauchu E; Ffrench M; Coiffier B; Magaud JP; Berger F; Salles GA; Traverse-Glehen A
    Br J Haematol; 2012 Jan; 156(2):279-81. PubMed ID: 21902683
    [No Abstract]   [Full Text] [Related]  

  • 6. Follicle center lymphoma is associated with significantly elevated levels of BCL-6 expression among lymphoma subtypes, independent of chromosome 3q27 rearrangements.
    Jardin F; Buchonnet G; Parmentier F; Contentin N; Leprêtre S; Lenain P; Picquenot JM; Laberge S; Bertrand P; Stamatoullas A; D'Anjou J; Tilly H; Bastard C
    Leukemia; 2002 Nov; 16(11):2318-25. PubMed ID: 12399978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of cyclin D1 mRNA overexpression in B-cell neoplasias by real-time reverse transcription-PCR of microdissected paraffin sections.
    Specht K; Kremer M; Müller U; Dirnhofer S; Rosemann M; Höfler H; Quintanilla-Martinez L; Fend F
    Clin Cancer Res; 2002 Sep; 8(9):2902-11. PubMed ID: 12231535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 expression in B-cell lymphomas.
    Gladkikh A; Potashnikova D; Korneva E; Khudoleeva O; Vorobjev I
    Exp Hematol; 2010 Nov; 38(11):1047-57. PubMed ID: 20727381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic features and differential diagnosis of splenic B-cell marginal zone lymphoma involving bone marrow].
    Sun Q; Zhang PH; Liu EB; Liu W; Li ZQ; Yang QY; Fang LH; Sun FJ; Chen HS; Qiu LG
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):234-8. PubMed ID: 23928529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma.
    Watkins AJ; Hamoudi RA; Zeng N; Yan Q; Huang Y; Liu H; Zhang J; Braggio E; Fonseca R; de Leval L; Isaacson PG; Wotherspoon A; McPhail ED; Dogan A; Du MQ
    PLoS One; 2012; 7(9):e44997. PubMed ID: 23028731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
    Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
    Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.
    Baseggio L; Traverse-Glehen A; Petinataud F; Callet-Bauchu E; Berger F; Ffrench M; Couris CM; Thieblemont C; Morel D; Coiffier B; Salles G; Felman P
    Haematologica; 2010 Apr; 95(4):604-12. PubMed ID: 20015887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
    Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
    Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenic marginal zone lymphoma.
    Piris MA; Onaindía A; Mollejo M
    Best Pract Res Clin Haematol; 2017; 30(1-2):56-64. PubMed ID: 28288718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole exome sequencing identifies novel recurrently mutated genes in patients with splenic marginal zone lymphoma.
    Parry M; Rose-Zerilli MJ; Gibson J; Ennis S; Walewska R; Forster J; Parker H; Davis Z; Gardiner A; Collins A; Oscier DG; Strefford JC
    PLoS One; 2013; 8(12):e83244. PubMed ID: 24349473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression to large B-cell lymphoma in splenic marginal zone lymphoma: a description of a series of 12 cases.
    Camacho FI; Mollejo M; Mateo MS; Algara P; Navas C; Hernández JM; Santoja C; Solé F; Sánchez-Beato M; Piris MA
    Am J Surg Pathol; 2001 Oct; 25(10):1268-76. PubMed ID: 11688461
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nodal and splenic marginal zone B cell lymphomas.
    Mollejo M; Camacho FI; Algara P; Ruiz-Ballesteros E; García JF; Piris MA
    Hematol Oncol; 2005; 23(3-4):108-18. PubMed ID: 16307458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In situ lymphoma].
    Chen DB; Dai L; Liao SL
    Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):790-2. PubMed ID: 20079026
    [No Abstract]   [Full Text] [Related]  

  • 19. 7q31-32 allelic loss is a frequent finding in splenic marginal zone lymphoma.
    Mateo M; Mollejo M; Villuendas R; Algara P; Sanchez-Beato M; Martínez P; Piris MA
    Am J Pathol; 1999 May; 154(5):1583-9. PubMed ID: 10329610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation of cyclin dependent kinase 6 expression in splenic marginal zone lymphoma through chromosome 7q translocations.
    Corcoran MM; Mould SJ; Orchard JA; Ibbotson RE; Chapman RM; Boright AP; Platt C; Tsui LC; Scherer SW; Oscier DG
    Oncogene; 1999 Nov; 18(46):6271-7. PubMed ID: 10597225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.